Adenomyosis
94
17
23
28
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.1%
2 terminated out of 94 trials
93.3%
+6.8% vs benchmark
7%
7 trials in Phase 3/4
7%
2 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (94)
Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Adenomyosis Clinical, Imaging and Histopathology
GyneFix IUD Plus LNG-IUS for Adenomyosis
Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients
The Good Pain Consultation in Endometriosis.
Radiofrequency Ablation of Adenomyosis
Transvaginal Electromechanical Fragmentation and Removal of Large Uterus in a Sealed Bag: The First Group of Clinical Studies Balancing Scar - Free and Anti - Dissemination
Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay
Central Sensitization in Women With Adenomyosis: Prevalence, Risk Factors, and Therapeutic Failure
Study of Endometrial Immune and Microbiological Modifications in Cases of Recurrent Implantation Failure and/or Recurrent Pregnancy Loss
FET in Adenomyosis
Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
Effect of Addition of Steroids on Duration of Analgesia
Clinical and Molecular Study of Endometriosis and Adenomyosis
Next-Generation Endometriosis Diagnostics Through Comprehensive Multi-Dimensional Analysis
Comparing the Efficacy of TU-LESS and vNOTES for Hysterectomy of Enlarged Uterus
A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes
Cohort Profile:The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)
Pain in Endometriosis And the Relation to Lifestyle
Electroacupuncture for Dysmenorrhea Secondary to Adenomyosis